Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sepideh Mehravaran"'
Autor:
Preeya Bhavsar‐Bhakta, Mugahed Hamza, Sepideh Mehravaran, Bhuvaneswari Krishnan, Qin He, Steven Tyring, Peter Rady, Gustavo Rivero, Daniel N. Cohen, Iberia Romina Sosa
Publikováno v:
eJHaem, Vol 2, Iss 2, Pp 228-235 (2021)
Abstract Patients with chronic lymphocytic leukemia (CLL), a B‐cell malignancy characterized by impaired humoral and cellular immunity, are at increased risk of developing cutaneous squamous cell carcinoma (cSCC). Human papilloma virus (HPV) is the
Externí odkaz:
https://doaj.org/article/15c09e124ffe44769689ab0425052653
Autor:
Jamunarani Veeraraghavan, Carolina Gutierrez, Vidyalakshmi Sethunath, Sepideh Mehravaran, Mario Giuliano, Martin J. Shea, Tamika Mitchell, Tao Wang, Sarmistha Nanda, Resel Pereira, Robert Davis, Kristina Goutsouliak, Lanfang Qin, Carmine De Angelis, Irmina Diala, Alshad S. Lalani, Chandandeep Nagi, Susan G. Hilsenbeck, Mothaffar F. Rimawi, C. Kent Osborne, Rachel Schiff
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-11 (2021)
Abstract Lapatinib (L) plus trastuzumab (T), with endocrine therapy for estrogen receptor (ER)+ tumors, but without chemotherapy, yielded meaningful response in HER2+ breast cancer (BC) neoadjuvant trials. The irreversible/pan-HER inhibitor neratinib
Externí odkaz:
https://doaj.org/article/9c0763f670574156a633837d6c948965
Autor:
Chandandeep Nagi, Sepideh Mehravaran
Publikováno v:
Diagnostic Histopathology. 26:88-95
Neoadjuvant therapy (NAT) is becoming a common approach to treat breast cancers. The most important advantage of NAT is the opportunity to evaluate the tumor response to treatment within few months after starting the medication. Pathology is the gold
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83c38cd31e557d9f2ad54aff3938a753
https://doi.org/10.1016/j.mpdhp.2019.10.017
https://doi.org/10.1016/j.mpdhp.2019.10.017
Publikováno v:
Radiographics : a review publication of the Radiological Society of North America, Inc. 42(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d439ff15eefaea4b8d37ca4a66c76c1d
https://pubmed.ncbi.nlm.nih.gov/34990323
https://pubmed.ncbi.nlm.nih.gov/34990323
Autor:
Jorge S. Reis-Filho, Nikhil Wagle, Ofir Cohen, Sepideh Mehravaran, Jamunarani Veeraraghavan, Resel Pereira, Myles Brown, Lanfang Qin, Bert W. O'Malley, Carmine De Angelis, Carolina Gutierrez, Vidyalakshmi Sethunath, Xiaoyong Fu, Rachel Schiff, Maria Letizia Cataldo, Sarmistha Nanda, Qin Feng, Mothaffar F. Rimawi, Gary C. Chamness, Rinath Jeselsohn, Britta Weigelt, Pier Selenica, Agostina Nardone, C. Kent Osborne
Publikováno v:
Proc Natl Acad Sci U S A
Forkhead box A1 (FOXA1) is a pioneer factor that facilitates chromatin binding and function of lineage-specific and oncogenic transcription factors. Hyperactive FOXA1 signaling due to gene amplification or overexpression has been reported in estrogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::524cedf1e32bed7312ca09dcdb1188ec
https://doi.org/10.1073/pnas.1911584116
https://doi.org/10.1073/pnas.1911584116
Autor:
Alshad S. Lalani, Sarmistha Nanda, Mario Giuliano, Tamika Mitchell, Jamunarani Veeraraghavan, Carmine De Angelis, C. Kent Osborne, Martin Shea, Chandandeep Nagi, Sepideh Mehravaran, Lanfang Qin, Kristina Goutsouliak, Irmina Diala, Robert Davis, Mothaffar F. Rimawi, Tao Wang, Susan G. Hilsenbeck, Vidyalakshmi Sethunath, Rachel Schiff, Resel Pereira, Carolina Gutierrez
Publikováno v:
NPJ Breast Cancer
npj Breast Cancer, Vol 7, Iss 1, Pp 1-11 (2021)
npj Breast Cancer, Vol 7, Iss 1, Pp 1-11 (2021)
Lapatinib (L) plus trastuzumab (T), with endocrine therapy for estrogen receptor (ER)+ tumors, but without chemotherapy, yielded meaningful response in HER2+ breast cancer (BC) neoadjuvant trials. The irreversible/pan-HER inhibitor neratinib (N) has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edaed2ac904def2f8e1fb6bad3d4e4f2
http://hdl.handle.net/11588/857292
http://hdl.handle.net/11588/857292
Autor:
Bhuvaneswari Krishnan, Sepideh Mehravaran, S. K. Tyring, Iberia Romina Sosa, Gustavo A. Rivero, Preeya Bhavsar, Mugahed Hamza, Peter Rady, Daniel Cohen, Qin He
Publikováno v:
Cancer Research. 80:4898-4898
Background: Human papilloma virus (HPV) is the most common sexually transmitted disease worldwide. α-genus HPV have oncogenic potential in anogenital skin and mucosa. Transplant patients have an increased incidence of β-genus HPV-associated cutaneo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d16cbfab134ea1ea13ece2b98a897a4
https://doi.org/10.1158/1538-7445.am2020-4898
https://doi.org/10.1158/1538-7445.am2020-4898
Publikováno v:
Biologics : Targets & Therapy
Glioma remains the most challenging solid organ tumor to treat successfully. Based on the capacity of stem cells to migrate extensively and target invading glioma cells, the transplantation of stem cells as a cell-based delivery system may provide ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb2c4402d67864e5e371d159e5bc499
http://europepmc.org/articles/PMC3104605
http://europepmc.org/articles/PMC3104605
Autor:
Mahnaz Aghaipoor, Esmerdis Hajati, Sepideh Mehravaran, Giti Irvanlou, Fereshteh Ensani, Zhamak Khorgami, Shahram Vaeli, Shirzad Nasiri
Publikováno v:
Diagnostic cytopathology. 40(4)
This prospective study aimed to compare the value of fine needle aspiration (FNA) cytology (FNAC) and flow cytometric immunophenotyping (FCI) with histopatopathology (HP) in the diagnosis and classification of non-Hodgkin lymphoma (NHL). Twenty-nine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec0ed7565d466382391d4e4e4e42c2fd
https://pubmed.ncbi.nlm.nih.gov/22431318
https://pubmed.ncbi.nlm.nih.gov/22431318
Publikováno v:
Biologics: Targets & Therapy; 2011, Vol. 5, p61-70, 10p